MOG and myeloid sarcoma: In previous work, absence of cell-based immunofluorescence assay MOG reactivity in MS patients and HDs (HD n = 13) was reported to depend on the use of a full-length human MOG α-1 isoform and an IgG1-specific secondary Ab at serum dilutions of 1:20 (32).